AstraZeneca
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Employees
- 89.9K
- Market Cap
- $270.3B
- Website
- http://www.astrazeneca.co.uk
- Introduction
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Retrospective Study in a NSCLC M+ p
- Conditions
- EGFR Mutated Non-small Cell Lung Cancer Patients
- First Posted Date
- 2013-02-20
- Last Posted Date
- 2013-10-30
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 187
- Registration Number
- NCT01795352
- Locations
- 🇪🇸
Research Site, Zaragoza, Spain
Physician Survey on Monitoring of Patients Treated With Quetiapine
- Conditions
- SchizophreniaBipolar DisorderMajor Depressive Disorder
- First Posted Date
- 2013-02-20
- Last Posted Date
- 2014-01-28
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 800
- Registration Number
- NCT01795326
EMR Data to Assess Monitoring of Patients Treated With Quetiapine
- Conditions
- Bipolar DisorderSchizophreniaMajor Depressive Disorder
- First Posted Date
- 2013-02-15
- Last Posted Date
- 2014-01-28
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 6153
- Registration Number
- NCT01793324
Extension Study for 2993-112
- First Posted Date
- 2013-02-12
- Last Posted Date
- 2015-02-24
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 225
- Registration Number
- NCT01789957
- Locations
- 🇺🇸
Diabetes, Endocrine and Nutrition Center, Bangor, Maine, United States
🇺🇸Metabolic Research Institute, Inc., West Palm Beach, Florida, United States
🇺🇸St. Agnes Health Care, Baltimore, Maryland, United States
Asia Pacific and Russia Diagnostic Study for EGFR Testing
- Conditions
- EGFR Mutation Status in aNSCLC Patients
- Interventions
- Genetic: EGFR mutation test
- First Posted Date
- 2013-02-11
- Last Posted Date
- 2017-05-17
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 3500
- Registration Number
- NCT01788163
- Locations
- 🇹🇭
Research Site, Patumwan Bangkok, Thailand
Acid-suppressing Drugs Pregnancy Asthma Offspring Study
- Conditions
- Asthma in Offspring
- Interventions
- Drug: Risk of asthma in offspring
- First Posted Date
- 2013-02-08
- Last Posted Date
- 2015-04-06
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 10116
- Registration Number
- NCT01787435
- Locations
- 🇪🇸
Research Site, Madrid, Spain
Europe-Japan Diagnostic Study for EGFR Testing
- Conditions
- EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.
- First Posted Date
- 2013-02-07
- Last Posted Date
- 2016-09-20
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 1311
- Registration Number
- NCT01785888
- Locations
- 🇬🇧
Research Site, Sheffield, United Kingdom
The Asthma Control Rate Achieved by Budesonide/Formoterol in Clinical Practice in China
- Conditions
- Asthma
- Interventions
- Other: without interventions
- First Posted Date
- 2013-02-07
- Last Posted Date
- 2016-08-19
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 1502
- Registration Number
- NCT01785901
- Locations
- 🇨🇳
Research Site, Wenzhou, Zhejiang, China
🇨🇳Research site, Hangzhou, Zhejiang, China
Level of Concordance Between Patients Perception and Physicians Evaluation of Cardiovascular Risk
- Conditions
- Cardiovascular Risk
- First Posted Date
- 2013-02-01
- Last Posted Date
- 2014-05-20
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 799
- Registration Number
- NCT01781416
- Locations
- 🇫🇷
Research Site, PARIS Cedex 15, France
Observation Study of the Clinical Management of Bipolar Disorder
- Conditions
- Bipolar Disorder
- First Posted Date
- 2013-01-18
- Last Posted Date
- 2016-04-07
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 520
- Registration Number
- NCT01770704
- Locations
- 🇨🇳
Research Site, Hangzhou, Zhejiang, China
🇨🇳Reserach Site, Shanghai, Shanghai, China
🇨🇳Research SIte, Kunming, Yunnan, China